By embracing a mix of co-innovation and best practices, stakeholders can boost productivity, streamline clinical trials, and ...

By granting creators and inventors exclusive rights to their work, IP laws provide a powerful incentive for individuals and ...

While significant progress has been made in developing treatments for rare diseases—highlighted by the approval of over 800 ...

The drug cytisinicline could help expand options for quitting smoking, and if approved by the FDA, would be the first new ...

It is now possible to obtain three-dimensional, high-resolution images of enzyme activity in tissue samples or whole ...

After a 20% cut to the FDA’s workforce, biotechs and pharmas are bracing for delays. But the impacts won’t be consistent.

The U.S. Food and Drug Administration announced earlier this month that it will be phasing out animal testing for some new ...

The FDA is phasing out animal testing and moving to more human-relevant methods. This was announced as one of Marty Makary’s ...

ORLANDO, Fla., April 30, 2025 (GLOBE NEWSWIRE) -- Nutriband Inc. (NASDAQ:NTRB) (NASDAQ:NTRBW) today announced that CEO Gareth ...

The DEA’s potential rescheduling of cannabis to a Schedule III drug could ease restrictions, boosting research and offering ...

Helen Branswell covers issues broadly related to infectious diseases, including outbreaks, preparedness, research, and vaccine development ... the approval process forward. In a new statement ...